Maven Pet has raised $4.42 million in funding to advance its AI-Vet™ platform aimed at early detection of health issues in pets and expand its presence in the U.S. market.

Target Information

Maven Pet, a startup based in Oporto, Portugal, has recently secured $4.42 million in funding to bolster the development of its pioneering product, AI-Vet™. This innovative platform utilizes artificial intelligence to facilitate early detection of health issues in pets, aiming to revolutionize pet healthcare. Founded in 2021 by four entrepreneurs—Guilherme Coelho, David Barroso, Paulo Fonseca, and Virgílio Bento (co-founder and CEO of Sword Health)—this is the company’s third round of investment, reflecting its growth and the confidence investors have in its vision.

The AI-Vet™ system represents the first AI-based pet health monitoring platform available globally. It assists veterinarians in proactively addressing health concerns by monitoring pets’ real-time data, including physical activity and critical health metrics, through technology embedded in a collar. This distinct approach allows for timely interventions, thereby enhancing the health and longevity of thousands of pets.

Industry Overview in Portugal

The pet healthcare market in Portugal is experiencing significant expansion, driven by the increasing focus on the well-being of pets among their owners. As more individuals view pets as

View Source

Similar Deals

Biovance Capital Mondego Bio

2025

Series A Bio Therapeutic Drugs Portugal
Grosvenor House of Investments, Portugal Ventures PeekMed

2021

Series A Medical Software & Technology Services Portugal
NOS 5G Fund, Triple Point Ventures knok

2021

Series A Telemedicine Services Portugal
Broadview Ventures and Advent Life Sciences Relief Cardiovascular

2025

Series A Medical Devices & Implants United States of America

Touro Capital Partners

invested in

Maven Pet

in 2024

in a Series A deal

Disclosed details

Transaction Size: $4M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert